Everything discussed below reflects findings from preclinical and in vitro studies, not clinical guidance
Tirzepatide is initiated at 2.5 mg subcutaneously once weekly for 4 weeks as a starting dose to improve gastrointestinal tolerability, then gradually titrated every 4 weeks up to a maximum of 15 mg weekly based on therapeutic response and tolerability
This is why a muscular person could be considered overweight, whereas someone with a normal BMI may have high body fat, which is linked to risks like type 2 diabetes or impaired glucose (Salmon-Gomez et al 2023)
The key is being proactive: eat smaller meals, avoid trigger foods, dont lie down after eating, and stay well-hydrated
The aforementioned restrictions have spurred increasing interest in herbal remedies and phytotherapeutics, which have traditionally been employed for ocular ailments and may provide multi-faceted therapeutic effects with potentially reduced adverse effects
Anecdotal reports of this concern circulate online without verified mechanistic explanation or documented cases
